193 related articles for article (PubMed ID: 22912560)
1. Cerebral lipiodol embolism after transarterial chemoembolization for hepatic carcinoma: a case report.
Jia ZZ; Tian F; Jiang GM
World J Gastroenterol; 2012 Aug; 18(30):4069-70. PubMed ID: 22912560
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report and literature review.
Naorungroj T; Naksanguan T; Chinthammitr Y
J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S270-5. PubMed ID: 23590054
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization.
Chu HJ; Lee CW; Yeh SJ; Tsai LK; Tang SC; Jeng JS
PLoS One; 2015; 10(6):e0129367. PubMed ID: 26107693
[TBL] [Abstract][Full Text] [Related]
4. Cerebral lipiodol embolism: a complication of transcatheter arterial chemoembolization for hepatocellular carcinoma.
Matsumoto K; Nojiri J; Takase Y; Egashira Y; Azama S; Kato A; Kitahara K; Miyazaki K; Kudo S
Cardiovasc Intervent Radiol; 2007; 30(3):512-4. PubMed ID: 17171304
[TBL] [Abstract][Full Text] [Related]
5. Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma.
Wu L; Yang YF; Liang J; Shen SQ; Ge NJ; Wu MC
World J Gastroenterol; 2010 Jan; 16(3):398-402. PubMed ID: 20082490
[TBL] [Abstract][Full Text] [Related]
6. Cerebral lipiodol embolism following abdomen trauma in a patient with hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Nie Q; Wu H; Guo P; Ge J; Qiu Y
Acta Neurol Belg; 2015 Sep; 115(3):459-61. PubMed ID: 25319130
[No Abstract] [Full Text] [Related]
7. Cerebral embolism of iodized oil (lipiodol) after transcatheter arterial chemoembolization for hepatocellular carcinoma.
Kim JT; Heo SH; Choi SM; Lee SH; Park MS; Kim BC; Kim Y; Kim MK; Cho KH
J Neuroimaging; 2009 Oct; 19(4):394-7. PubMed ID: 19496902
[TBL] [Abstract][Full Text] [Related]
8. Cerebral lipiodol embolism after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Takao H; Makita K; Doi I; Watanabe T
J Comput Assist Tomogr; 2005; 29(5):680-2. PubMed ID: 16163042
[TBL] [Abstract][Full Text] [Related]
9. [Cerebral lipiodol embolism after transcatheter arterial chemoembolization of hepatocellular carcinoma].
Chung PJ; Park SY; Kim YI; Yoon KW; Cho SB; Choi SK; Rew JS
Korean J Gastroenterol; 2009 Aug; 54(2):130-4. PubMed ID: 19696542
[TBL] [Abstract][Full Text] [Related]
10. Pancreas lipiodol embolism induced acute necrotizing pancreatitis following transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and literature review.
Tan Y; Sheng J; Tan H; Mao J
Medicine (Baltimore); 2019 Nov; 98(48):e18095. PubMed ID: 31770228
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary embolism after arterial chemoembolization for hepatocellular carcinoma: an autopsy case report.
Hatamaru K; Azuma S; Akamatsu T; Seta T; Urai S; Uenoyama Y; Yamashita Y; Ono K
World J Gastroenterol; 2015 Jan; 21(4):1344-8. PubMed ID: 25632211
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic pulmonary lipiodol embolism after transarterial chemoembolization for hepatic malignant tumor: clinical presentation and chest imaging findings.
Xu H; Yang R; Wang X; Zhu X; Chen H
Chin Med J (Engl); 2014; 127(4):675-9. PubMed ID: 24534221
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma.
Matsumoto T; Ichikawa H; Imai J; Hayashi T; Tomita K; Mine T; Kojima S; Watanabe N; Hasebe T
Anticancer Res; 2017 Jun; 37(6):3183-3187. PubMed ID: 28551662
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents.
Chen S; Yu W; Zhang K; Liu W; Chen Q
Medicine (Baltimore); 2018 May; 97(21):e10832. PubMed ID: 29794774
[TBL] [Abstract][Full Text] [Related]
16. Cerebral lipiodol embolism related to a vascular lake during chemoembolization in hepatocellular carcinoma: A case report and review of the literature.
Ishimaru H; Morikawa M; Sakugawa T; Sakamoto I; Motoyoshi Y; Ikebe Y; Uetani M
World J Gastroenterol; 2018 Oct; 24(37):4291-4296. PubMed ID: 30310262
[TBL] [Abstract][Full Text] [Related]
17. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review.
Idée JM; Guiu B
Crit Rev Oncol Hematol; 2013 Dec; 88(3):530-49. PubMed ID: 23921081
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for the development of pulmonary oil embolism after transcatheter arterial chemoembolization of hepatic tumors.
Wu GC; Chan ED; Chou YC; Yu CY; Hsieh TY; Hsieh CB; Chian CF; Ke FC; Dai YL; Su WL
Anticancer Drugs; 2014 Sep; 25(8):976-81. PubMed ID: 24736105
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.
de Baere T; Arai Y; Lencioni R; Geschwind JF; Rilling W; Salem R; Matsui O; Soulen MC
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):334-43. PubMed ID: 26390875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
